Clinical Trial

Vitaccess Real CIDP Registry

Study acronym: VRCIDP
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Vitaccess Real CIDP (VRCIDP) is a patient registry designed to capture longitudinal observational data on chronic inflammatory demyelinating polyneuropathy (CIDP), its treatment, and impact on symptoms, daily activities, and quality of life (QoL). The duration of the registry is 10 years from launch, and approximately 300 patients will be recruited in the US and Europe with no defined upper limit. The registry will link relevant patient- and healthcare professional (HCP)-reported data with clinical data from electronic medical records (EMR). Patient reported and eCRF data will be linked via a unique ID and PIN assigned to each participant at enrolment. Patients will be recruited at clinical sites in all participating countries. In the US only, patients can additionally be recruited via community neurologists or direct-to-patient recruitment.
Trial Details
NCT Number NCT07006597
Lead Sponsor Vitaccess Ltd
Conditions Chronic Inflammatory Demyelinating Polyneuropathy, CIDP
Enrollment 300 participants
Start Date 2025-07-31
Primary Completion 2035-07 (estimated)
Study Completion 2035-07 (estimated)
Updated on ClinicalTrials.gov 2025-06-05